The following pages link to Nigel Stallard (Q961162):
Displaying 20 items.
- Optimal Adaptive Designs for Binary Response Trials (Q65284) (← links)
- Repeated measures proportional odds logistic regression analysis of ordinal score data in the statistical software package R (Q961163) (← links)
- A parametric multistate model for the analysis of carcinogenicity experiments (Q1126007) (← links)
- Estimation following selection of the largest of two normal means (Q2480019) (← links)
- Optimal adaptive designs for acute oral toxicity assessment (Q2492920) (← links)
- Point estimates and confidence regions for sequential trials involving selection (Q2573521) (← links)
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials (Q2874297) (← links)
- Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations (Q2980231) (← links)
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865) (← links)
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies (Q3079128) (← links)
- Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution (Q4634681) (← links)
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685) (← links)
- A Comparison of Methods for Adaptive Treatment Selection (Q5123111) (← links)
- Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R (Q5135525) (← links)
- Determination of the optimal sample size for a clinical trial accounting for the population size (Q5280174) (← links)
- Uniformly minimum variance conditionally unbiased estimation in multi-arm multi-stage clinical trials (Q5384602) (← links)
- A Hierarchical Bayesian Model for Predicting the Functional Consequences of Amino-Acid Polymorphisms (Q5757751) (← links)
- Estimating Numbers of Infectious Units from Serial Dilution Assays (Q5757810) (← links)
- Adaptive enrichment designs with a continuous biomarker (Q6055888) (← links)
- Rejoinder to discussion on “Adaptive enrichment designs with a continuous biomarker” (Q6055894) (← links)
